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of Native Coarctation of the Aorta
An Observational Study by the CCISC
(Congenital Cardiovascular Interventional Study Consortium)
Objectives The purpose of this study was to compare the safety and efficacy of surgical, stent, and balloon angioplasty (BA)
treatment of native coarctation acutely and at follow-up.
Background Controversy surrounds the optimal treatment for native coarctation of the aorta. This is the first multicenter
study evaluating acute and follow-up outcomes of these 3 treatment options in children weighing 10 kg.
Methods This is a multicenter observational study. Baseline, acute, short-term (3 to 18 months), and intermediate
(18 months) follow-up hemodynamic, imaging data, and complications were recorded.
Results Between June 2002 and July 2009, 350 patients from 36 institutions were enrolled: 217 underwent stent,
61 underwent BA, and 72 underwent surgery. All 3 arms showed significant improvement acutely and at
follow-up in resting systolic blood pressure and upper to lower extremity systolic blood pressure gradient
(ULG). Stent was superior to BA in achieving lower ULG acutely. Surgery and stent were superior to BA at
short-term follow-up in achieving lower ULG. Stent patients had shorter hospitalization than surgical pa-
tients (2.4 vs. 6.4 days; p  0.001) and fewer complications than surgical and BA patients (2.3%, 8.1%,
and 9.8%; p  0.001). The BA patients were more likely to encounter aortic wall injury, both acutely and at
follow-up (p  0.001).
Conclusions Stent patients had significantly lower acute complications compared with surgery patients or BA patients,
although they were more likely to require a planned reintervention. At short-term and intermediate follow-
up, stent and surgical patients achieved superior hemodynamic and integrated aortic arch imaging out-
comes compared with BA patients. Because of the nonrandomized nature of this study, these results should
be interpreted with caution. (J Am Coll Cardiol 2011;58:2664–74) © 2011 by the American College of
Cardiology Foundationi
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hThe past 5 decades have seen many improvements in
therapeutic options for treatment of native coarctation of
the aorta in children and adults. The first surgery was
performed in 1944 by Drs. Crawford and Nylin, with
refinement of surgical technique being accomplished over
the past 4 decades (1,2). The transcatheter approach to
this lesion was first performed using balloon angioplasty
(BA) in the 1980s (3), with intravascular stent treatment
gaining wider acceptance in the 1990s (4). At many
institutions, the transcatheter approach has become the
treatment of choice for children and adults with native
coarctation of the aorta (5). Unfortunately follow-up for
all 3 types of treatment has been limited, making it
difficult to draw any meaningful conclusions as to which
treatment option is superior. The issue is further com-
plicated by uncertainty as to what constitutes an accept-
*From the Children’s Hospital of Michigan, Detroit, Michigan; †Children’s Healthcare
of Atlanta, Atlanta, Georgia; ‡Nationwide Children’s Hospital, Columbus, Ohio;
§Lavasani/Beheshti Medical Center, Tehran, Iran; Children’s Hospital of Philadelphia,
Philadelphia, Pennsylvania; ¶Rush University Medical Center, Chicago, Illinois; #Arnold
Palmer Hospital, Orlando, Florida and the Miami Children’s Hospital, Miami, Florida;
**Primary Children’s Medical Center, Salt Lake City, Utah; ††Riley Children’s Hospital,
Indianapolis, Indiana; ‡‡Akron Children’s Hospital, Akron, Ohio; §§Amplatzer Chil-
dren’s Hospital, Minneapolis, Minnesota;  Hope Children’s Hospital, Oak Lawn,
llinois; ¶¶Saint Louis Children’s Hospital, St. Louis, Missouri; ##Pittsburgh Children’s
ospital, Pittsburgh, Pennsylvania; ***Children’s Hospital of Central California, aable upper to lower extremity systolic blood pressure
gradient (ULG) after repair. Although data were col-
lected for both recurrent and native coarctation of the
aorta, the main controversy remains as to which treat-
ment should be used for correction of native coarctation
of the aorta, which is the focus of this paper. The primary
objective of this study is to compare the safety and
efficacy of surgical, stent, and BA treatment of native
coarctation of the aorta acutely, at short-term and inter-
mediate follow-up.
Methods
Study population and design. This prospective, multi-
institutional, observational study included the participation
of 36 centers from the Congenital Cardiovascular Interven-
tional Study Consortium (CCISC). A complete listing of
Fresno, California; †††Mayo Clinic, Rochester, Minnesota; ‡‡‡Children’s National
Medical Center, Washington, DC; §§§University of Virginia, Charlottesville, Virginia;
and the   University of Texas Southwestern Medical Center, Dallas, Texas. Dr. Turner
s a consultant for Cardia Inc.; and a proctor for Gore and AGA. Dr. Hoyer is a consultant
nd proctor (and receives compensation) for AGA Medical (part of St. Jude Medical); and
s a consultant (and receives compensation) for Gore Medical. Dr. Zellers is a proctor for
GA Medical; and a consultant for WL Gore. All other authors have reported that they
ave no relationships relevant to the contents of this paper to disclose.
Manuscript received May 9, 2011; revised manuscript received August 3, 2011,
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Treatment of Native Coarctation of the Aorta December 13/20, 2011:2664–74participating centers can be found
in the Online Appendix. Treat-
ment options (surgical, stent, or
BA) were based on institutional/
interventionalist preference. In-
stitutional review board approvals
were obtained from each institu-
tion before participation in the
study. Inclusion and exclusion
criteria are summarized in Table
1. Case report forms for the ini-
tial intervention, reintervention,
and short-term (3 to 18 months)
and intermediate follow-up (18
to 60 months) were filled out
under supervision of the partici-
pating physician and entered di-
rectly onto a secure CCISC da-
tabase. Possible confounders of
treatment options including in-
stitutional experience, patient age, weight, and coarctation
anatomy were evaluated using logistic regression. Follow-up
imaging by computed tomography (CT), magnetic reso-
nance imaging (MRI), or catheterization was considered
standard of care by participating institutions. All initial,
follow-up, and reintervention imaging studies were re-
viewed by core laboratory physicians.
Data collection. PRE-INTERVENTION DATA. Patient demo-
raphics such as age, weight, sex, and associated diagnosis
ere recorded. Baseline clinical information included upper
nd lower extremity systolic/diastolic blood pressures (BP),
urrent antihypertensive medications, pre-operative CT,
RI, or catheterization measurements of the long axis of
he aorta, coarctation type (discrete vs. long segment), and
ocation.
PROCEDURAL DATA. Type of surgical repair and catheter-
ization pre- and post-intervention hemodynamics in stent
patients and BA patients were obtained. If the systolic
Abbreviations
and Acronyms
BA  balloon angioplasty
BP  blood pressure
Coarct:Dao  ratio
narrowest coarctation
dimension to aorta
dimension at level of
diaphragm
CT  computed
tomography
MRI  magnetic resonance
imaging
OR  odds ratio
TAA  transverse aortic
arch
ULG  upper to lower
extremity systolic blood
pressure gradient
Inclusion and Exclusion CriteriaTable 1 Inclusion and Exclusion Criteria
1. Inclusion criteria
a. Body weight 10 kg
b. Presence of significant native coarctation based on the following:
1. ULG 20 mm Hg
2. ULG 10 mm Hg with either decreased LV function (EF 30%) or
moderate to severe aortic insufficiency
3. ULG 10 mm Hg plus significant collateral flow
2. Exclusion criteria
a. Body weight 10 kg
b. Refusal to sign consent
c. Requiring other surgical procedures that would entail correction of the
coarctation segment in the same setting
d. Known or suspected arteritis
e. Recurrent coarctation of the aortaa
EF ejection fraction; LV left ventricular; ULG upper to lower extremity systolic blood pressure
radient.pressure gradient from ascending to descending aorta post-
intervention, measured by direct pullback measurement, was
10 mm Hg, a distal transverse aortic arch BP measure-
ment was recorded to assess potential obstruction at the
level of the transverse aortic arch.
The narrowest vessel measurements were recorded in 2
separate projections in antero-posterior/left anterior oblique
and lateral view at the transverse aortic arch, coarctation
segment, and aorta at the level of the diaphragm. Biplane
angiography was performed pre-intervention, and orthogonal
views were obtained post-intervention to rule out aortic arch
pathology.
DISCHARGE DATA. Discharge date, upper and lower ex-
remity BP, complications, and antihypertensive medica-
ions were recorded. Determination for using antihyperten-
ive medications was by institutional preference.
FOLLOW-UP DATA. Imaging studies (MRI, cardiac cathe-
terization, or multislice CT) were performed at short-term
and intermediate follow-up. Patient demographics, upper
and lower extremity BP, and antihypertensive medications
were recorded at time of imaging study.
REINTERVENTION DATA. Indications for reintervention
nd whether it was planned or unplanned were docu-
ented. Hemodynamic and angiographic parameters
imilar to those obtained during original intervention
ere recorded.
efinition of coarctation/transverse aortic arch anatomy.
roximal coarctation was defined as a coarctation segment
ocated 10 mm from the origin of the left subclavian
rtery, with distal coarctation being defined as a coarctation
egment located 10 mm from the origin of the left
ubclavian artery. Hypoplastic transverse aortic arch (TAA)
as defined as TAA (mm) divided by descending aorta
easured at the level of the diaphragm (mm [Dao]) ratio
0.6. Aneurysm was defined as a diameter 20% than the
ao (that is, not considered to be post-stenotic dilation of
he aorta) or an abnormal localized enlargement of the aortic
egment.
utcome assessments. HEMODYNAMIC OUTCOME. Systolic
BP gradient measured from upper to lower extremities
(ULG) at time of discharge, follow-up, and reintervention
were used as the primary hemodynamic outcomes. These
outcomes were dichotomized using 10 and 15 mm Hg ULG
as cut-offs. The systolic gradient measured at coarctation
site directly by catheter (ascending to descending aorta) pre-
and post-treatment for stent and BA patient groups was also
recorded.
ANGIOGRAPHIC OUTCOME. The coarctation repair site di-
ension was compared to the aortic diameter at the level of
he diaphragm (Coarct:Dao). Follow-up outcomes were
ssessed by MRI/CT or catheterization measurements of
he coarctation repair site. For surgical outcome, it is
ssumed that the initial surgical diameter would be the same
s the proximal vessel diameter.
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December 13/20, 2011:2664–74 Treatment of Native Coarctation of the AortaSAFETY ENDPOINT. Safety endpoints were death, aortic wall
njury, other procedural complications, and unanticipated
eintervention acutely and at short-term and intermediate
ollow-up.
REOBSTRUCTION. A filling defect within a previously
placed stent was considered neointimal proliferation. Reob-
struction of the coarctation repair site was deemed mild
(10% narrowing of vessel/stent lumen), moderate (11% to
30% narrowing), or severe (30% narrowing).
POST-OPERATIVE HYPERTENSION. Definition of severe
ost-operative/post-interventional hypertension was persis-
ent systolic BP 95% for the patient’s height and weight
asting 48 h after initial intervention and requiring intra-
enous medical therapy.
CORE LABORATORY ASSESSMENT. All imaging data were
reviewed at 1 of 4 core laboratory centers: Nationwide
Children’s Hospital, Columbus, Ohio; National Children’s
Medical Center, Washington, DC; University of Texas
Southwestern Medical Center, Dallas, Texas; and Penn
State University, Hershey, Pennsylvania.
Statistical methods. To compare patient baseline charac-
teristics among treatment groups, chi-square tests or anal-
ysis of variance along with Tukey’s multiple comparison
tests were used. Association between various patient char-
acteristics and outcomes was assessed using chi-square or
Fisher’s exact tests and analysis of variance. Multinomial
logistic regression was performed to identify factors affect-
ing treatment choices to be used in multivariate adjustment
Baseline CharacteristicsTable 2 Baseline Characteristics
Age, yrs
Age range, yrs
Weight, kg
Male
Pre-intervention right-arm SBP, mm Hg
Pre-intervention ULG
Pre-intervention catheterization SBP gradient
Pre-intervention coarctation measurement, mm/BSA
Coarctation location
Isthmus
Distal
Proximal
Transverse aorta
Complex
Abdominal/thoracic aorta
Bicuspid aortic valve
Other CHD diagnosis
Catheterization laboratory patient volume
Large
Medium
Small
Values are mean SD, min/max, and %. *p  0.05.
BSA  body surface area; CHD  congenital heart disease; NA  not avail
systolic blood pressure gradient.when comparing outcomes between treatment arms. Logis-
tic and linear regressions were performed to compare
outcomes between treatment groups while adjusting for
confounders. The log-rank test was used to compare time to
unplanned reintervention among the 3 treatment groups.
Subgroup analysis limiting patient age to between 6 and 12
years was conducted to confirm results obtained in larger
samples. Any p value 0.05 was considered statistically
significant, and SAS version 9.2 software (SAS Institute,
Cary, North Carolina) was used for all analyses.
Results
In all, 350 patients were enrolled between June 1, 2002, and
October 31, 2010, from 36 institutions; of those patients,
217 underwent stent, 61 underwent BA, and 72 underwent
surgical repair of their native coarctation segment.
Procedural technique. Seventy-two patients underwent
surgical repair of coarctation. Sixty-three percent underwent
end-to-end anastomosis repair, 17% tube graft interposi-
tion, 14% patch angioplasty, and 6% subclavian flap repair.
Two hundred seventeen patients underwent 236 stent pro-
cedures. Nineteen patients required a second stent, due to
stent migration in 6 patients or to cover the entire coarcta-
tion segment in the remaining patients.
Baseline characteristics. Table 2 compares baseline pa-
tient characteristics among the 3 treatment groups. Patients
undergoing stent treatment were significantly older and
weighed more than those undergoing BA or surgical treat-
ment (p  0.001). Stent patients had a significantly smaller
ery
72)
Balloon
(n  61)
Stent
(n  217)
p Value
(2-Sided)
9.7 9.0 8.0 16.6 10.9 0.001*
58.6 0.4/42.5 2.2/74.3
24 30 21 55 24 0.001*
% 64% 69% 0.750
19 138 23 143 21 0.061
21 43 23 40 24 0.399
A 38.7 36.7 0.459
A 5.8 4.3 0.001*
0.212
% 95% 90%
% 63% 71%
% 32% 19%
2% 8%
2% 1%
2% 1%
% 46% 40% 0.708
% 5% 9% 0.308
0.090
% 67% 66%
% 23% 19%
% 10% 15%Surg
(n 
10.0
0.1/
35
69
137
37
N
N
86
56
31
7%
5%
0%
40
13
60
14
26able; SBP  systolic blood pressure; ULG  upper to lower extremity
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Treatment of Native Coarctation of the Aorta December 13/20, 2011:2664–74pre-intervention coarctation measurement to body surface area
ratio than the BA patients (p  0.001). No coarctation
easurement was available for surgical patients. Catheteriza-
ion laboratory patient volume had no correlation with treat-
ent option. There were no other anatomic, clinical, or
emographic differences among the 3 groups. In a multinomial
ogistic regression, age and weight were found to be the only 2
ignificant confounders (p  0.001) of treatment choice.
re-intervention coarctation measurement was not entered
nto the regression because it was not available for surgical
atients.
cute hemodynamic and angiographic outcomes. H-
emodynamic outcomes were assessed by the pre-
intervention and discharge ULG measured noninvasively.
All 3 treatment modalities showed a significant decrease in
the pre- versus post-intervention ULG. Table 3 depicts the
mean ULG for the 3 groups, as well as ULG at cut-offs of
10 and 15 mm Hg. A significant difference was observed
between stent and BA groups (p  0.032). Using a cut-off
radient of 10 mm Hg, stent remained superior to BA (p 
.005) and trended toward superiority to surgery in univar-
ate analysis. When controlling for age and weight in
ultivariate analyses, the stent group remained superior to
A in achieving lower gradient (p  0.008), with no
ifferences observed between stent and surgery. The post-
ntervention catheterization systolic gradient from ascend-
ng to descending aorta was significantly higher in the BA
roup than in the stent group (p 0.001), with multivariate
nalyses confirming the univariate results.
Comparing measurements of the coarctation segment,
ignificant improvement was observed in both the BA group
nd the stent group after intervention. However, the percent
mprovement in measurement was significantly higher in
Acute OutcomesTable 3 Acute Outcomes
Post-intervention right-arm SBP, mm Hg
Discharge ULG
Discharge ULG 10 mm Hg
Discharge ULG 15 mm Hg
Post-intervention catheterization SBP gradient
% Increase in coarctation measurement post-intervention
Any complications
Aortic wall injury
Dissection/intimal tear
Aneurysm
Balloon rupture
Stent migration
Femoral
Atrial fibrillation
Severe/prolonged hypertension
Length of stay, days
Values are mean SD, %, or mean/median. *p 0.05. †Complicatio
pleural effusion, neurological/spinal cord injury, chylothorax, and voc
routinely evaluated for surgical patients.
Abbreviations as in Table 2.he stent group in both univariate (p  0.008) and multi-
ariate analysis (p  0.01).
cute adverse events. No deaths occurred in any group.
omplications associated with BA patients were primarily
elated to aortic wall injury. Both the surgical group and BA
roup had a greater likelihood of encountering complica-
ions than the stent group (p  0.001) (Table 3). Surgical
omplications included spinal injury (n  1), which was
bserved in an 8-year-old child with remaining deficits over
years out from the procedure, sustained post-operative
trial fibrillation (n 2), severe post-operative hypertension
n  2), prolonged pleural effusion (n  3), vocal cord
aralysis (n  1), and left facial paresis with complete
ecovery noted 2 months later. In the stent group, 1 patient
ad a large femoral hematoma, and 3 patients experienced
tent migration during the procedure. When comparing the
isk of all complications between treatment arms while
djusting for confounders, stent was safer than BA (odds
atio [OR]: 5.72; 95% confidence interval: 1.59 to 20.52;
 0.008) and surgery (OR: 11.23; 95% confidence
nterval: 3.66 to 34.51; p  0.001). Lastly, surgical patients
ad a longer mean length of hospital stay as compared with
tent patients.
ollow-up outcomes. The mean follow-up (using the
atest follow-up time) was 1.9 years (range 0.1 to 5.8 years)
n 68% of the stent patients, 2.1 years (range 0.07 to 9.09
ears) in 77% of the BA patients, and 1.9 years (range 0.1 to
.7 years) in 81% of the surgical patients. No deaths were
eported. All patients described in this section underwent
ollow-up imaging per study protocol with no clinical
oncerns expressed by the attending cardiologist that
rompted the imaging studies.
urgery
 72)
Balloon
(n  61)
Stent
(n  217)
p Value
(2-Sided)
3 13 118 15 125 15 0.002*
7 18.2 10.3 12.9 4.9 13.2 0.032
64% 56% 76% 0.011*
73% 69% 81% 0.101
NA 12.4 12.2 4.8 8.6 0.001*
NA 125% 172% 0.008*
8.1%† 9.8% 2.3% 0.001*
UK‡ 9.8% 0.0% 0.001*
UK‡ 9.8% 0.0%
UK‡ 0.0% 0.0%
NA 0.0% 0.5%
NA n/a 1.4%
UK‡ 0.0% 0.5%
3% 0% 0%
3% 0% 0%
.4/5.0 3.6/1.0 2.4/1.0 0.001*
rienced by surgical patients are severe hypertension, atrial fibrillation,
paralysis. ‡Unknown (UK), as these types of complications are notS
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December 13/20, 2011:2664–74 Treatment of Native Coarctation of the AortaShort-term follow-up. We defined short-term follow-up
as any clinical evaluation and/or integrated imaging between
3 and 18 months from the initial procedure. A total of 125
stent, 37 BA, and 52 surgical patients underwent short-term
follow-up evaluations; of these, 78%, 75%, and 50% under-
went integrated imaging, respectively.
HEMODYNAMIC OUTCOMES. There were no significant dif-
ferences in percent of patients with normalized BP at
short-term follow-up among the 3 treatment groups, al-
though the BA group showed a trend toward having the
lowest percent of patients with normalized systolic BP
(Table 4). Patients undergoing stent or surgical repair were
more likely to be taking antihypertensive medications than
BA patients (p  0.019). Logistic regression adjusting for
ntihypertensive medications showed that BA patients con-
inued to have the lowest percent with normal systolic BP.
he adjusted difference was significant between BA patients
nd stent patients (OR: 0.292; p  0.011), but not between
A and surgical patients (OR: 0.365; p  0.072). Univar-
ate and multivariate analysis showed a significant advantage
f the surgical group and stent group over the BA group in
chieving ULG 10 (p  0.001) and 15 mm Hg (p 
.004) (Table 4).
INTEGRATED IMAGING OUTCOMES. The mean Coarct:Dao
atio was significantly higher in the surgical patients versus
he BA patients (p  0.015), with no differences in
achieving Coarct:Dao ratio 0.60 among the 3 groups
(Table 4). Aortic wall injury was significantly greater in the
BA group than in the stent group (21.4% vs. 3.1%; p 
0.004), primarily because of aneurysm formation (Table 5).
In all BA patients, and in all but 1 stent case, the aneurysms
were localized to the area of coarctation. In 1 stent case, the
aneurysm was observed just proximal to the previously
placed stent (Fig. 1A), with progression observed at follow-
up, and was treated with a covered stent (Fig. 1B and 1C).
All other aneurysms post-transcatheter intervention are
small (5 mm) and localized. Surgical aneurysms were
observed with the subclavian flap and patch onlay tech-
niques and tended to be more diffuse (Fig. 2A and 2B).
ultivariate logistic regression indicated that the stent
Short-Term Follow-Up OutcomesTable 4 Short-Term Follow-Up Outcomes
Outcomes
Surgery
(n  52)
Age at follow-up, yrs 12.1 10.9
Weight at follow-up, kg 41.3 30.6
Normal SBP* 84.6%
Antihypertensive medications 40%
Right-arm SBP, mm Hg 114 17
ULG 1.2 21.5
ULG 10 mm Hg 89%
ULG 15 mm Hg 91%
Values are mean SD or %. *Defined as 97.5 percentile SBP of no
Abbreviations as in Table 2.roup was significantly less likely to encounter aortic wallnjury than the BA group (OR: 0.08; 95% confidence
nterval: 0.02 to 0.39; p  0.002), with no differences
bserved between the surgical group and stent groups.
Angiographic reobstruction was noted with equal frequency
n all 3 treatment groups, with BA showing the greatest
ropensity toward developing reobstruction at short-term
ollow-up (Table 5). Mild stent restenoses were secondary to
tent recoil (EV3 stents) in 2 and moderate restenosis second-
ry to stent fracture (Genesis XD stent) in 1 patient.
ntermediate follow-up. We defined intermediate follow-up
s any clinical evaluation and/or integrated imaging between
8 and 60 months from the initial procedure. A total of 77
tent, 25 BA, and 23 surgical patients underwent intermediate
ollow-up evaluation. Of these, 73%, 64%, and 70% underwent
ntegrated imaging studies, respectively.
HEMODYNAMIC OUTCOMES. There were no significant dif-
ferences in resting hypertension among the 3 groups;
however, the BA group trended toward having higher
percent of hypertension than the stent and surgical groups
(Table 6). Logistic regression adjusting for antihypertensive
medications indicated that BA patients continued to have
the lowest percent of normalized BP. The adjusted differ-
ence was significant between BA and surgical patients (OR:
Balloon
(n  37)
Stent
(n  125)
p Value
(2-Sided)
10.4 9.2 17.2 10.1 0.001†
34.4 22.4 59.3 21.9 0.001†
72.2% 87.2% 0.096
16% 41% 0.019†
118 14 121 13 0.005†
9.9 16.8 0.9 13.9 0.011†
35% 75% 0.001†
65% 86% 0.004†
bjects (age and sex adjusted). †p  0.05.
Short-Term Follow-Up Outcomesby Integ ated ImagingTable 5 Sh rt-Term Follow-Up Outcomesby Integrated Imaging
Outcomes
Surgery
(n  26)
Balloon
(n  28)
Stent
(n  97)
p Value
(2-Sided)
Any complications* 23.1% 32.1% 8.3% 0.003‡
Aortic wall Injury 11.5% 21.4% 3.1% 0.004‡
Dissection/intimal tear 0.0% 7.1% 0.0% 0.062
Aneurysm 11.5% 14.3% 3.1% 0.040‡
Coarct:Dao ratio, mean 0.91 0.73 0.82 0.003‡
Coarct:Dao 0.6 87.0% 79.0% 90.0% 0.247
Any reobstruction 19.2% 32.1% 15.4% 0.057
Mild† 7.7% 17.9% 11.3%
Moderate 7.7% 3.6% 4.1%
Severe 3.9% 10.7% 0%
*Defined as any moderate to severe reobstruction, aortic wall injury (aneurysm, dissection, intimal
tear) or stent fracture. †Mild reobstruction was not considered as a complication in our analysis.
‡p  0.05.Coarct:Dao narrowest coarctation dimension (mm)/the dimension of the descending aorta at
the level of the diaphragm (mm).
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and stent patients (OR: 0.581; p  0.309). When compar-
ing mean ULG among the 3 treatment groups, no signifi-
cant differences were found, although when using a cut-off
of 10 mm Hg, the surgical group showed an advantage over
BA (p  0.030).
INTEGRATED IMAGING OUTCOMES. The mean Coarct:Dao
atio in surgical patients was significantly higher than in the
A patients or stent patients (p  0.011), with no differ-
nces in percent achieving Coarct:Dao ratio 0.60 among
he 3 groups (Table 7). Aneurysms were more common in
A patients (p  0.001), with no progression in aneurysm
ize observed in any patient at a mean follow-up of 24
onths (range 18 to 64 months). Re-intervention due to
neurysm formation was required in 1 stent patient. A small
Figure 1 Stent-Related Complication
(A to C) Figure 1A depicts a small localized aneurysm in the proximal stent 4 yea
Figure 1B at 8-year follow-up which required covered Cheatham-Platinum stent plac
Figure 2 Pre-Surgical Native Coarctation of the Aorta and Post
(A) Pre-surgical coarctation segment in a 3-year-old child is shown. Severe discret
present, with no post-stenotic dilation of the descending aorta observed. (B) Angio
measuring 2.7 cm, and the aorta at the level of the diaphragm measuring 1.8 cm
stented at this catheterization.neurysm was observed 4 years out from the procedure, with
n interval increase in aneurysm sized observed 8 years out
rom initial stent placement which required placement of a
overed stent (Figs. 1A, 1B, and 1C).
eintervention. Fifty-four patients had reinterventions
erformed at a mean of 1.7 years after the initial procedure.
hese were further divided into anticipated and unantici-
ated reinterventions (Table 8). Anticipated reinterventions
ere performed either because of a staged approach or
econdary to patient somatic growth. Except for the stent
neurysm case noted above, unanticipated reinterventions
ere due exclusively to reobstruction, with no differences
bserved among the 3 groups. The primary reason for
nanticipated reintervention in the stent group was second-
ry to neointimal proliferation in 6 patients and stent
r initial stent placement. Progression was observed in aneurysm size depicted in
t which is noted in Figure 1C.
ical Aneurysm
ctation with isthmus hypoplasia is observed. Numerous intercostal collaterals are
shows aneurysm formation 3.5 years out from the surgery, with the repair site
was recoarctation at the distal transverse aorta, which was subsequentlyrs afte
emen-Surg
e coar
gram
. There
rmal su
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reintervention both in the BA group and the surgical group
was secondary to recurrent scarring at the coarctation site,
with the majority being treated with stent placement. Mean
Coarct:Dao ratios were calculated for pre-intervention (0.25),
immediate post-intervention (0.66), pre-reintervention
(0.59), and post-reintervention (0.85). Analyses determin-
ing statistical differences between treatment groups were not
performed because most of the reinterventions observed
were planned and the number of unanticipated reinterven-
tion was extremely small.
Subgroup analysis. Subgroup analysis restricting patients’
age to 6 to 12 years was conducted (Table 9). The ULG
measured immediately after the procedure remained signif-
icantly lower in the stent and surgical patients when
compared with BA patients (p  0.050). The overall acute
complication rate was significantly higher in BA and surgical
patients (p  0.035). When examining short-term follow-up
outcomes, the surgical group remained superior in achieving a
lower ULG compared with the BA group (p  0.004). Stent
and surgical repair continued to show a higher percentage of
patients with normal BP when compared to BA patients.
Short-term follow-up complication rates (both overall and
aortic wall) remained lower in the stent group versus the BA
Intermediate Follow-Up OutcomesTable 6 Intermediate Follow-Up Outcomes
Surgery
(n  23)
Age at follow-up 15.0 11.2
Weight at follow-up 57.4 22.4
Normal SBP* 96%
Antihypertensive medications 13%
Right-arm SBP, mm Hg 115 9
ULG 1.4 13.9
ULG 10 mm Hg 90%
ULG 15 mm Hg 95%
Values are mean SD or %. *Defined as 97.5 percentile SBP of no
Abbreviations as in Table 2.
Intermediate Follow-up Outcomesby Integrated ImagingTable 7 Intermediate Follow-up Outcomesby Integrated Imaging
Surgery
(n  16)
Balloon
(n  16)
Stent
(n  56)
p Value
(2-Sided)
Any complications* 25.0% 43.8% 12.5% 0.020‡
Aortic wall injury 12.5% 43.8% 7.1% 0.003‡
Dissection/intimal tear 0.0% 6.3% 1.8% 0.598
Aneurysm 12.5% 43.8% 5.4% 0.001
Coarct:Dao ratio, mean 0.98 0.79 0.80 0.011‡
Coarct:Dao ratio 0.6 88% 93% 89% 1.000
Any reobstruction 18.8% 18.8% 14.3% 0.923
Mild† 6.3% 18.8% 12.5%
Moderate 6.3% 0% 1.8%
Severe 6.3% 0% 0%
*Defined as any moderate to severe reobstruction, aortic wall injury (aneurysm, dissection, intimal
tear) or stent fracture. †Mild reobstruction was not considered as a complication in our analysis.
‡p  0.05.Coarct:Dao narrowest coarctation dimension (mm)/the dimension of the descending aorta at
the level of the diaphragm (mm).group. No statistically significant differences in short-term
follow-up complication rates were observed between the BA
group versus surgical group or between the stent group versus
surgical group, most likely because of the small sample size.
There was no correlation between age and antihypertensive
medication use observed in this subgroup analysis. Analysis
describing intermediate-term follow-up outcomes are not pre-
sented here because of relatively small sample size.
Discussion
Coarctation of the aorta comprises 4% to 5% of all congen-
ital heart defects. Native coarctation has historically been
treated by surgery. Recently, transcatheter approaches have
been increasingly refined, in part because of increased
operator experience, and also because of improved balloon
and stent technology, which has translated to improved
safety and success of these procedures. As a result, numerous
institutions have reported success with transcatheter treat-
ment of native coarctation (5–7). Controversy has sur-
rounded the growing trend to treat native coarctation of the
aorta by the transcatheter route. Analyzing prior studies to
evaluate a superior treatment to this disease has been
difficult due to the majority of series having low volumes and
inconsistent follow-up. In our review of the literature, there
were only 3 studies that directly compared surgery to BA
(8–10), and none compared surgery to stent treatment of
aortic coarctation. Cowley et al. (9) noted that at follow-up,
the BA group showed a significantly greater propensity for
aneurysm formation and need for reintervention in comparison
to surgery, with our study supporting their contention regard-
ing aneurysm formation but not the need for reintervention.
The remaining comparative studies noted inconsistent follow-
up. Ours is the first multi-institutional observational study that
attempts to answer which treatment option for the treatment
of native coarctation of the aorta in patients weighing 10 kg
is optimal. In our study, surgical and BA patients were
significantly younger and of lower weight than patients under-
going stent treatment, with no other anatomic, clinical, or
demographic differences observed among the 3 groups.
Regarding the surgical group, it was surprising with
Balloon
(n  25)
Stent
(n  77)
p Value
(2-Sided)
12.9 6.5 18.3 9.8 0.035†
40.3 16.2 60.8 18.6 0.001†
72% 82% 0.092
16% 31% 0.130
122 13 123 13 0.044†
5.5 14.3 1.9 13.7 0.118
55% 75% 0.032†
82% 85% 0.421
bjects (age and sex adjusted). †p  0.05.regard to the number of patients who underwent tube graft
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ment. Performing an end-to-end anastomosis with coarc-
tation resection would seem to be the preferred procedure
(11). In this experience, the requirement for tube graft
interposition or onlay patch augmentation of the coarctation
segment increased significantly as the child reached teenage
years. That may be particularly true in circumstances where
long segment coarctation (5 mm) is present (12–14). Only
42% of the patients 8 years of age, 25% of patients 12
years of age, and none 16 years of age were able to
undergo end-to-end repair of their coarctation segment.
Hemodynamic outcomes. Hemodynamic outcome pa-
rameters were the most difficult metric used to define
success versus failure while developing the study. To date,
no evidence-based criteria for ULG have been established to
define a successful repair. Furthermore, the majority of
studies use recorded gradients immediately after repair,
measured intraoperatively or in the catheterization labora-
tory while under anesthesia, which can lead to underesti-
mating the true gradient. Few people would disagree that an
ULG 10 mm Hg is a success; however, past studies have
rbitrarily defined success as 20 mm Hg systolic gradient
across coarctation segment (8,10). The ultimate aim for any
coarctation repair is the resolution of the ULG, as persistent
hypertension can be observed in as many as 50% of patients
even with a “perfect” repair, particularly if initial repair is
performed after 1 year of age (15–17). To complicate
matters further, exercise treadmill testing does not predict
ReinterventionTable 8 Reintervention
(
Patients with reintervention
Patients with planned procedures
Patients with unplanned procedures
Time to first planned reintervention, yrs
Time to first unplanned reintervention, yrs 2.
Values are n or mean SD.
NA  not available.
Subgroup Analysis, Age 6 to 12 YearsTable 9 Subgroup Analysis, Age 6 to 12 Ye
Surgery
Acute outcome n 23
Age, yrs 8.7 2.1
Discharge ULG 2.3 12.9
Any complications 13.0%
Aortic wall complications NA
Short-term follow-up outcome n 18
Antihypertensive
medications
44%
Normal SBP* 89%
ULG 4.9 14.3
Any complications 25%
Aortic wall complications 13%Values are mean SD or %. *Defined as 97.5 percentile SBP of normal su
Abbreviations as in Table 2.the severity of aortic arch reobstruction (16,17). In our
study, stent and surgical groups appeared to have an
advantage over the BA group in achieving lower BP
gradients at acute and short-term follow-up, with these
differences disappearing among the 3 groups at intermediate
follow-up. The preferential use of antihypertensive medica-
tions in surgical patients may be in part related to the
manipulation of the aorta and increased likelihood of
surgical patients encountering post-operative hypertension
as well as increased ULG, both of which resolved over time.
Angiographic outcomes. Review of the literature revealed
no evidence to support the determination of successful
treatment of coarctation of the aorta on the basis of
angiographic outcomes alone. In normal patients, the aortic
isthmus is 80% to 90% of transverse aortic diameter and
similar to descending aortic diameter at level of the dia-
phragm by angiographic imaging (18). The CCISC expe-
rience, consistent with others (19,20), confirmed that the
majority of patients requiring reintervention for recoarcta-
tion had a Coarct:Dao ratio of 0.60. In determining the
definition of clinically significant TAA hypoplasia, we
believe that a ratio of TAA:Dao 0.60, similar to our
experience with Coarct:Dao ratio, would likely require
future intervention and, therefore, should be addressed at
time of coarctation repair.
Complications. The stent group was superior to both the
surgical group and the BA group regarding the incidence of
acute complications in all patients and in the subset of
y
2)
Balloon
(n  61)
Stent
(n  217)
6 44
2 35
4 9
1.43 1.70 1.14 1.15
.23 1.28 1.43 2.84 1.43
alloon Stent p Value (2-Sided)
n 23 n 57
.6 2.1 9.3 1.8 0.301
.1 14.3 2.9 10.6 0.050†
13.0% 1.8% 0.035†
13.0% 0.0% 0.022†
n 14 n 32
0% 28% 0.018†
79% 84% 0.728
.2 16.5 2.0 11.3 0.016†
38% 4% 0.010†
31% 0% 0.009†Surger
n  7
4
0
4
NA
24 2ars
B
8
10
10bjects (age and sex adjusted). †p  0.05.
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group, acute complications were due almost exclusively to
aortic wall injury. Acute dissections and aortic ruptures have
been described in both procedures, with the majority occur-
ring in older patients (12,21,22). Acute aortic dissection or
rupture was not encountered in this study. One possible
reason for this may be related to the increased approach to
staging the procedure in patients with severe native coarctation
of the aorta. The development of an acute dissection/aortic
rupture after transcatheter treatment of the coarctation seg-
ment is equally prevalent in native versus recurrent coarctation
and is not related to balloon/coarctation ratio (5,23).
In this experience, the likelihood of encountering aortic
wall injury of any type at follow-up was significantly higher
in the BA group than in the surgical group and stent group,
a finding that is also consistent to what was observed in the
literature (24). Hassan et al. (25) noted an aneurysm rate of
7.5%, all observed at 1-year angiographic evaluation, which
is significantly less than what we observed. That may be due,
in part, to their patient cohort being significantly older (25).
In contrast to surgical patients, aneurysm formation in BA
patients and stent patients typically occurs within the first
year after the transcatheter procedure (25,26), with rare
situations observed where progression of the aneurysm
required covered stent or surgical treatment (26,27). We
observed “late” aneurysm formation in only 3 patients—2
after BA and 1 after stent placement. The patients had
normal MRI/CT scans ranging from 7 to 24 months after
initial intervention, with small aneurysms noted between 3.2
and 4.0 years. We observed the lowest aneurysm rate in our
stent group (Table 6). Prevention of an intimal tear has been
advanced as to why initial stent implantation may protect
against later aneurysm formation (28). There is evidence
that exceeding a balloon:coarctation ratio of 4 and per-
formance of pre-stent BA may increase the risk of encoun-
tering aneurysm formation at intermediate follow-up
(26,29). Aneurysm formation in the surgical group (11.5%
at short term and 12.5% at intermediate term) occurred
exclusively in the subclavian flap and onlay patch tech-
niques. The development of late aneurysms has been re-
ported in all types of surgical repair. More recently, there
appears to be improvement in avoidance of encountering
surgical aneurysms, with 9% of patients overall having local
aneurysms late after surgical repair (30,31). There were 2
patients, 1 in the stent group and 1 in the surgical group,
who were noted to have aneurysm formation at short-term
follow-up and had imaging at intermediate follow-up. No
progression in aneurysm size was noted in either patient. In
the stent patient who required covered stent placement for
treatment of an aneurysm, the initial aneurysm was first
observed at intermediate follow-up.
Reintervention. Planned repeat intervention was most
likely in the stent group, at 16.1%. In the experience of
CCISC, staged procedures were nearly exclusively observed
among patients undergoing stent treatment for severe native
coarctation of the aorta. The staged approach has beenadvocated to decrease the likelihood of encountering large
aneurysms, which were encountered in our early experience.
That appears to have been successful, as we have not
encountered any large aneurysms in any of the stent patients
at short-term or intermediate follow-up. In the Quebec
Native Coarctation Study, at a mean of 38 months, 32% of
the transcatheter patients required reintervention (32). In
their stent patients, the study made no distinction between
anticipated (staged) and unanticipated reintervention. Un-
fortunately, there are no strict criteria for performing a
reintervention, which our data clearly indicated. Of the 17
patients undergoing unanticipated reintervention due to
recurrent obstruction, 6 (35%) had a resting systolic BP
130 mm Hg and an upper to lower extremity resting
systolic BP gradient 15 mm Hg prior to reintervention.
The Coarct:Dao ratio of 0.60 appears to be an important
ratio regarding the requirement for reintervention. Al-
though there were others who underwent reintervention
with a ratio of 0.60, the vast majority had a ratio 0.60.
Study limitations. This is a not a randomized study.
Although we noted no treatment bias related to the catheter-
ization volume of a particular institution, many centers sup-
plied fewer than 10 subjects to the study. Therefore, because of
low numbers, a potential treatment bias relating to catheter-
ization volume could have been overlooked. We did observe a
bias toward surgery and balloon angioplasty in the younger
patient. It would also be logical to presume that not every
participating institution enrolled every eligible patient into the
study. Therefore, selection bias for entry into the study could
not be ruled out. Finally, although compliance was reasonable
in obtaining integrated follow-up imaging at the prescribed
times, we still fell short of comprehensive evaluation of all
subjects. One could not rule out the possibility of an upward
bias in the estimation of aortic wall complications at follow-up
by excluding patients from analysis who did not undergo
integrated imaging at follow-up.
Conclusions
In this large multi-institutional observational study, we at-
tempted to determine which of the 3 modalities for the
treatment of native coarctation had better patient outcomes in
terms of hemodynamic improvement, complications, and re-
intervention acutely and at short-term and intermediate
follow-up. To adjust for age and size difference, we conducted
multivariate analysis as well as a subgroup analysis limiting
patient age to 6 to 12 years. Stent patients had significantly
lower acute complications compared to surgery patients and
BA patients. At short-term and intermediate follow-up, stent
and surgical patients achieved superior hemodynamic and
integrated aortic arch imaging outcomes compared to BA
patients. Stent patients were more likely to require a planned
reintervention, with no differences observed among the 3
groups regarding the need for performing unplanned reinter-
ventions. End-to-end resection of the native coarctation seg-
ment was not able to be performed in the majority of surgical
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of this study, these results should be interpreted with caution.
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APPENDIX
For a list of CCISC coarctation participating institutions,16. Vriend JW, Van Montfrans GA, Romkes HH, et al. Relation between
exercise-induced hypertension and sustained hypertension in adult please see the online version of this article.
Go to http://cme.jaccjournals.org
to take the CME quiz for this article.
